Fund Holdings — AJU IB Investment Co., Ltd.

Total Portfolio Value:
$84.04M
Total Bought:
$0
Total Sold:
$0
Net Transaction:
$0
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Arcellx Inc
COMMON STOCK
1,047,5571,047,5570$80.34M$68.72M81.77%-$11.62M
Kymera Therapeutics, Inc.(KYMR)457,059457,0590$18.39M$12.51M14.88%-$5.88M
Seer, Inc.CL A(SEER)816,375816,3750$1.89M$1.38M1.64%-$506.2K
Rallybio Corporation(RLYB)754,678754,6780$724.5K$493.9K0.59%-$230.6K
Xilio Therapeutics, Inc.(XLO)667,742667,7420$637.7K$483.7K0.58%-$154.0K
Carisma Therapeutics Inc718,332718,3320$300.8K$222.7K0.26%-$78.2K
Rapt Therapeutics Inc99,50399,5030$157.2K$121.4K0.14%-$35.8K
Sutro Biopharma, Inc.(STRO)175,000175,0000$322.0K$113.9K0.14%-$208.1K
Page 1 of 1
AJU IB Investment Co., Ltd. — 13F Holdings — Q1 2025 | TickerTrail